Ariel Blumovich
Ariel Blumovich is a seasoned entrepreneur and executive with over 17 years of healthcare and FoodTech experience in various management positions, in companies such as Samsung, Teva, Sanofi and Enzymotec. Ariel is the founder of YDL Ventures – a biotech advisory firm supporting pharma R&D projects. Ariel holds a B.Sc. in Mechanical Engineering from the Israeli Technion, and an MBA from Tuck Business School at Dartmouth.
YDLabs
Meet the Next-Gen of Revolutionary Fermentation and Large-Scale Biomanufacturing
-
Contract Development and Manufacturing Organizations (CDMOs) are at the forefront of fermentation. Rather than waste money building fermentation capacity from scratch, companies can transform their biomanufacturing processes with external experts. By leveraging their collective experience and economies of scale, CDMOs can harness the power of engineered organisms to drive innovation and efficiency across diverse industries. By seamlessly integrating fermentation with cutting-edge synthetic biology techniques, these global facilities not only boost productivity but also promote environmental sustainability. Through decades of in-house knowledge, strategic industry collaborations, and an unwavering commitment to shaping the future of biotechnology, our leading team isn’t merely anticipating trends; we are actively creating them.
Conference Pass
2,495
USD
Keynotes & Firesides
Workshops & Breakouts
1:1 Partnering App
Meals & Receptions
Session Recordings
Until Friday April 18th
Full Rate:
$3,495